Kilitch Drugs (India) Ltd

NSE: KILITCH BSE: 524500

₹316.10

(-0.69%)

Sun, 22 Mar 2026, 07:51 am

MTF 5xInvest in Kilitch Drugs (India) Ltd with 5x Leverage Buy with MTF

Market Cap5.51B

PE Ratio20.17

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Kilitch Drugs (India) Income Statement

Income Statement Balance Sheet Cashflow

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	244.30M	323.84M	1.17B	1.29B	1.43B	1.46B	1.08B	319.90M	141.28M	183.46M	203.47M	272.55M	509.62M	823.97M	532.92M	683.97M	1.14B	1.40B	1.54B	1.98B
Gross profit	237.77M	295.16M	166.75M	1.23B	217.00M	206.55M	127.99M	-21.73M	8.61M	37.58M	-55.69M	-15.98M	144.71M	224.09M	111.56M	188.63M	337.12M	426.91M	552.83M	711.31M
Operating expenses (excl. COGS)	-237.09M	-272.87M	-1.12M	-1.05B	-40.99M	-41.73M	-52.97M	-39.18M	-66.76M	-70.27M	-89.31M	-75.83M	-104.78M	-161.61M	-124.78M	-152.44M	-247.27M	-281.62M	-339.20M	-421.12M
Selling/general/admin expenses, total	-18.51M	-28.26M	—	-42.44M	-40.99M	-41.73M	-52.97M	-39.18M	-66.76M	-62.75M	-70.78M	-80.02M	-68.99M	-161.60M	-124.78M	-140.49M	-247.26M	-281.62M	-339.20M	-421.12M
Research & development	—	—	—	—	—	0	0	0	0	0	0	0	—	—	—	—	0	0	0	—
Selling/general/admin expenses, other	-18.51M	-28.26M	—	-42.44M	-40.99M	-41.73M	-52.97M	-39.18M	-66.76M	-62.75M	-70.78M	-80.02M	-68.99M	-161.60M	-124.78M	-140.49M	-247.26M	-281.62M	-339.20M	-421.12M
Other operating expenses, total	-218.57M	-244.61M	-1.12M	-1.01B	0	0	0	0	0	-7.52M	-18.53M	4.19M	-35.80M	-3.00K	-3.00K	-11.96M	-3.00K	0	0	0
Operating income	685.00K	22.30M	165.64M	176.15M	176.01M	164.82M	75.02M	-60.92M	-58.15M	-32.69M	-145.00M	-91.82M	39.93M	62.48M	-13.23M	36.19M	89.85M	145.29M	213.63M	290.20M
Non-operating income, total	5.83M	-9.35M	-38.72M	-49.38M	-40.54M	-33.66M	898.61M	93.67M	68.78M	23.20M	28.71M	-1.33M	21.20M	23.39M	29.32M	15.03M	6.31M	-25.13M	-20.07M	54.55M
Interest expense, net of interest capitalized	0	-9.91M	-40.05M	-51.04M	-45.35M	-35.76M	-28.95M	-839.00K	0	-507.00K	-631.00K	-1.55M	-4.16M	-6.48M	-9.38M	-8.77M	-13.31M	-50.83M	-60.36M	-53.20M
Interest capitalized	0	0	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-operating income, excl. interest expenses	5.83M	565.00K	1.33M	1.66M	4.81M	2.10M	1.08B	94.51M	69.74M	28.20M	31.87M	267.00K	25.36M	29.87M	38.70M	23.80M	19.62M	25.70M	40.30M	107.75M
Non-operating interest income	95.00K	157.00K	496.00K	95.00K	1.16M	1.27M	4.65M	5.63M	1.87M	4.51M	1.37M	1.63M	2.20M	1.64M	1.64M	1.70M	2.19M	3.02M	4.08M	35.95M
Miscellaneous non-operating expense	5.74M	408.00K	833.00K	1.56M	3.65M	825.00K	1.08B	88.89M	67.88M	23.69M	30.50M	-1.32M	23.18M	28.26M	37.06M	22.09M	17.43M	22.68M	36.22M	71.81M
Unusual income/expense	—	—	—	—	—	—	-155.28M	—	-965.00K	-4.50M	-2.53M	-48.00K	—	-2.00K	0	0	0	0	0	0
Pretax income	6.52M	12.95M	126.92M	126.77M	135.48M	131.16M	973.63M	32.76M	10.63M	-9.48M	-116.29M	-93.15M	61.13M	85.87M	16.10M	51.22M	96.16M	120.16M	193.56M	344.75M
Taxes	-2.25M	-1.50M	-13.71M	-15.33M	-28.51M	-26.28M	-210.52M	71.00K	1.14M	6.59M	4.38M	4.26M	-9.60M	-47.57M	-7.65M	-13.53M	-34.01M	-37.32M	-57.79M	-95.34M
Non-controlling/minority interest	0	0	0	0	0	-90.00K	0	0	0	0	0	0	0	0	0	-955.00K	11.54M	21.65M	10.26M	17.61M
After tax other income/expense	0	0	0	0	—	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	4.27M	11.44M	113.21M	111.44M	106.96M	104.79M	763.11M	32.83M	11.77M	-2.89M	-111.91M	-88.90M	51.52M	38.30M	8.42M	36.71M	73.67M	104.48M	146.01M	267.01M
Net income	4.27M	11.44M	113.21M	111.44M	106.96M	104.79M	763.11M	32.83M	11.77M	-2.89M	-111.91M	-88.90M	51.52M	38.30M	8.42M	36.71M	73.67M	104.48M	146.01M	267.01M
Dilution adjustment	0	0	0	0	-4.65M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	4.27M	11.44M	113.21M	111.44M	102.32M	104.79M	763.11M	32.83M	11.77M	-2.89M	-111.91M	-88.90M	51.52M	38.30M	8.42M	36.71M	73.67M	104.48M	146.01M	267.01M
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	7.21M	50.97M	230.19M	239.57M	238.83M	222.79M	123.75M	-48.63M	-43.75M	-14.06M	-44.35M	5.73M	60.36M	82.99M	6.76M	56.05M	114.51M	180.79M	247.13M	321.30M
EBIT	685.00K	22.30M	165.64M	176.15M	176.01M	164.82M	75.02M	-60.92M	-58.15M	-32.69M	-145.00M	-91.82M	39.93M	62.48M	-13.23M	36.19M	89.85M	145.29M	213.63M	290.20M
Total operating expenses	-243.61M	-301.54M	-1.01B	-1.11B	-1.25B	-1.30B	-1.00B	-380.82M	-199.43M	-216.14M	-348.47M	-364.37M	-469.69M	-761.49M	-546.14M	-647.78M	-1.05B	-1.25B	-1.33B	-1.69B
Prepaid expenses	6.04M	8.07M	13.01M	24.68M	3.50M	7.16M	88.00K	60.00K	648.00K	712.00K	152.00K	10.00K	—	453.00K	103.00K	261.00K	497.00K	1.58M	859.00K	1.98M
Deferred income, current	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	2.80M	4.19M	3.49M	4.42M	—	—	2.63M	2.54M	1.51M	—	—	—	—	—	—	—	—	—	—	—
Deferred income, non-current	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	15.66M	10.78M	0	0	0	0	0	7.31M	20.97M	22.18M	23.50M	12.07M	-10.17M	-6.18M	-18.71M
Change in accrued expenses	—	—	—	—	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	-15.45M	-15.45M	-15.10M	-15.45M	-14.94M	-461.38M	0	-151.00K	-703.00K	-403.00K	-408.00K	-9.50M	-17.90M	0	-11.98M	0	0	0
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800